# CHGB

## Overview
The CHGB gene encodes the protein chromogranin B, a member of the granin family of acidic secretory proteins. Chromogranin B is predominantly found in the secretory granules of neuroendocrine cells, where it plays a crucial role in the regulated secretory pathway. This protein is involved in the formation and maturation of secretory granules, which are essential for the storage and release of peptide hormones and neurotransmitters. Chromogranin B functions as an anion channel, contributing to the maintenance of ion gradients across membranes, which is vital for cellular homeostasis and signaling (Yadav2019Membrane; Yadav2023Chromogranin). The gene and its protein product have been implicated in various physiological processes and pathological conditions, including type 2 diabetes, schizophrenia, and amyotrophic lateral sclerosis (Shin2017GenderSpecific; GrosLouis2009Chromogranin; Bearrows2019Chromogranin).

## Structure
Chromogranin B (CHGB) is a secretory protein with a complex molecular structure. The primary structure of CHGB consists of a polypeptide chain of 657 amino acids, with a molecular weight of approximately 76 kDa. It includes a cleaved N-terminal signal peptide of 20 residues, which targets the protein to the endoplasmic reticulum (Benedum1987The). The protein is highly hydrophilic and rich in charged amino acids, lacking a long hydrophobic domain (Benedum1987The).

CHGB contains two cysteine residues in the N-terminal domain, which form intramolecular disulfide bonds, contributing to its stability (Benedum1987The). The protein also undergoes post-translational modifications, including tyrosine sulfation at specific sites, which may influence its function (Benedum1987The).

In terms of secondary structure, CHGB features amphipathic α-helices, particularly helices 1 and 3, which are involved in membrane association and channel formation (Yadav2018Secretory). The quaternary structure of CHGB involves its ability to form oligomers, transitioning from dimers to tetramers, which are crucial for its function as an anion channel in membranes (Yadav2018Secretory). These structural features enable CHGB to play a significant role in cellular processes, particularly in neuroendocrine cells.

## Function
Chromogranin B (CHGB) is a protein that plays a critical role in the regulated secretory pathways of exocrine, endocrine, and neuronal cells. It is involved in the formation and maturation of secretory granules, which are essential for the storage and release of peptide hormones and neurotransmitters. CHGB forms highly selective anion channels that help maintain ion gradients across membranes, crucial for preventing the breakdown of these gradients and minimizing the loss of organic anionic metabolites (Yadav2019Membrane).

In pancreatic islet β-cells, CHGB is vital for the efficient trafficking of insulin granules from the Golgi apparatus to the plasma membrane. It ensures the proper distribution and function of insulin granules, impacting glucose-stimulated insulin secretion and proinsulin processing. The loss of CHGB leads to impaired insulin secretion, increased proinsulin content, and altered granule density, which are associated with characteristics of type 2 diabetes (Bearrows2019Chromogranin).

CHGB also contributes to the formation of dominant anion channels on the cell surface following granule exocytosis, which are important for maintaining ion homeostasis in secretory granules. These channels facilitate granule release and compensate for local charge imbalances during calcium influx (Yadav2023Chromogranin).

## Clinical Significance
Mutations and alterations in the CHGB gene have been implicated in several diseases. In schizophrenia, specific single nucleotide polymorphisms (SNPs) in the CHGB gene, such as rs910122 and rs2821, have shown significant associations with the disorder, particularly in certain populations. These genetic variants may influence susceptibility to schizophrenia, with some studies indicating gender-specific effects, especially in males (Shin2017GenderSpecific; Zhang2002Polymorphisms; Iijima2004Association).

In amyotrophic lateral sclerosis (ALS), the P413L variant of the CHGB gene is associated with an increased risk and earlier onset of the disease. This variant is overrepresented in ALS patients compared to controls and is thought to affect the sorting and maturation of CHGB into secretory granules, potentially contributing to ALS pathogenesis (GrosLouis2009Chromogranin).

Altered CHGB expression is also observed in various conditions. It is reduced in diseases like schizophrenia and Alzheimer's disease, while overexpressed in conditions such as pheochromocytoma and prostate cancer. In pheochromocytoma and paraganglioma, CHGB expression levels may help differentiate between metastatic and non-metastatic forms (Wang2022Value; Mahapatra2006Molecular).

## Interactions
Chromogranin B (CHGB) is involved in various protein interactions that are crucial for its function in neuroendocrine cells. CHGB forms heterodimeric and heterotetrameric complexes with Chromogranin A (CgA) at different pH levels, indicating significant protein-protein interactions that may play a role in calcium signaling and the sorting and trafficking of peptide hormones and neuropeptides to secretory granules (Greenwood2004Genomewide). 

CHGB is also involved in the formation of anion channels, which are essential for granule release. It can form tetrameric channels with two pores, contributing to significant cell-surface anion conductances. These channels are highly selective for anions and can be reconstituted in membranes, suggesting that CHGB can function independently in channel formation (Yadav2023Chromogranin). 

In the context of granule biogenesis and maturation, CHGB interacts with other granin family proteins, such as secretogranin II (SgII) and secretogranin III (SgIII), which are involved in the sorting mechanisms within the trans-Golgi network (Bartolomucci2011The). These interactions facilitate the formation of immature granules that mature into dense core granules, essential for the regulated secretory pathway.


## References


[1. (Benedum1987The) U. M. Benedum, A. Lamouroux, D. S. Konecki, P. Rosa, A. Hille, P. A. Baeuerle, R. Frank, F. Lottspeich, J. Mallet, and W. B. Huttner. The primary structure of human secretogranin i (chromogranin b): comparison with chromogranin a reveals homologous terminal domains and a large intervening variable region. The EMBO Journal, 6(5):1203–1211, May 1987. URL: http://dx.doi.org/10.1002/j.1460-2075.1987.tb02355.x, doi:10.1002/j.1460-2075.1987.tb02355.x. This article has 173 citations.](https://doi.org/10.1002/j.1460-2075.1987.tb02355.x)

[2. (Yadav2023Chromogranin) Gaya P. Yadav, Haiyuan Wang, Joke Ouwendijk, Stephen Cross, Qiaochu Wang, Feng Qin, Paul Verkade, Michael X. Zhu, and Qiu-Xing Jiang. Chromogranin b (chgb) is dimorphic and responsible for dominant anion channels delivered to cell surface via regulated secretion. Frontiers in Molecular Neuroscience, June 2023. URL: http://dx.doi.org/10.3389/fnmol.2023.1205516, doi:10.3389/fnmol.2023.1205516. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2023.1205516)

[3. (Shin2017GenderSpecific) Joong-Gon Shin, Jeong-Hyun Kim, Chul Soo Park, Bong-Jo Kim, Jae Won Kim, Ihn-Geun Choi, Jaeuk Hwang, Hyoung Doo Shin, and Sung-Il Woo. Gender-specific associations betweenchgbgenetic variants and schizophrenia in a korean population. Yonsei Medical Journal, 58(3):619, 2017. URL: http://dx.doi.org/10.3349/ymj.2017.58.3.619, doi:10.3349/ymj.2017.58.3.619. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3349/ymj.2017.58.3.619)

[4. (Greenwood2004Genomewide) Tiffany A. Greenwood, Peter E. Cadman, Mats Stridsberg, Susan Nguyen, Laurent Taupenot, Nicholas J. Schork, and Daniel T. O’Connor. Genome-wide linkage analysis of chromogranin b expression in the ceph pedigrees: implications for exocytotic sympathochromaffin secretion in humans. Physiological Genomics, 18(1):119–127, June 2004. URL: http://dx.doi.org/10.1152/physiolgenomics.00104.2003, doi:10.1152/physiolgenomics.00104.2003. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1152/physiolgenomics.00104.2003)

[5. (Iijima2004Association) Yoshimi Iijima, Toshiya Inada, Tsuyuka Ohtsuki, Hisashi Senoo, Masaki Nakatani, and Tadao Arinami. Association between chromogranin b gene polymorphisms and schizophrenia in the japanese population. Biological Psychiatry, 56(1):10–17, July 2004. URL: http://dx.doi.org/10.1016/j.biopsych.2004.03.012, doi:10.1016/j.biopsych.2004.03.012. This article has 18 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.biopsych.2004.03.012)

[6. (Yadav2018Secretory) Gaya P Yadav, Hui Zheng, Qing Yang, Lauren G Douma, Linda B Bloom, and Qiu-Xing Jiang. Secretory granule protein chromogranin b (chgb) forms an anion channel in membranes. Life Science Alliance, 1(5):e201800139, September 2018. URL: http://dx.doi.org/10.26508/lsa.201800139, doi:10.26508/lsa.201800139. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.26508/lsa.201800139)

[7. (Mahapatra2006Molecular) Nitish R. Mahapatra, Manjula Mahata, Sajalendu Ghosh, Jiaur R. Gayen, Daniel T. O’Connor, and Sushil K. Mahata. Molecular basis of neuroendocrine cell type‐specific expression of the chromogranin b gene: crucial role of the transcription factors creb, ap‐2, egr‐1 and sp1. Journal of Neurochemistry, 99(1):119–133, July 2006. URL: http://dx.doi.org/10.1111/j.1471-4159.2006.04128.x, doi:10.1111/j.1471-4159.2006.04128.x. This article has 27 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/j.1471-4159.2006.04128.x)

[8. (Bartolomucci2011The) Alessandro Bartolomucci, Roberta Possenti, Sushil K. Mahata, Reiner Fischer-Colbrie, Y. Peng Loh, and Stephen R. J. Salton. The extended granin family: structure, function, and biomedical implications. Endocrine Reviews, 32(6):755–797, August 2011. URL: http://dx.doi.org/10.1210/er.2010-0027, doi:10.1210/er.2010-0027. This article has 254 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1210/er.2010-0027)

[9. (Zhang2002Polymorphisms) Bifeng Zhang, Zheng Tan, Changshun Zhang, Yongyong Shi, Zhixin Lin, Niufan Gu, Guoyin Feng, and Lin He. Polymorphisms of chromogranin b gene associated with schizophrenia in chinese han population. Neuroscience Letters, 323(3):229–233, May 2002. URL: http://dx.doi.org/10.1016/s0304-3940(02)00145-3, doi:10.1016/s0304-3940(02)00145-3. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0304-3940(02)00145-3)

[10. (GrosLouis2009Chromogranin) Francois Gros-Louis, Peter M. Andersen, Nicolas Dupre, Makoto Urushitani, Patrick Dion, Frederique Souchon, Monique D’Amour, William Camu, Vincent Meininger, Jean-Pierre Bouchard, Guy A. Rouleau, and Jean-Pierre Julien. Chromogranin b p413l variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences, 106(51):21777–21782, December 2009. URL: http://dx.doi.org/10.1073/pnas.0902174106, doi:10.1073/pnas.0902174106. This article has 49 citations.](https://doi.org/10.1073/pnas.0902174106)

11. (Yadav2019Membrane) Membrane insertion of chromogranin B for granule maturation in regulated secretion. This article has 1 citations.

[12. (Bearrows2019Chromogranin) Shelby C. Bearrows, Casey J. Bauchle, McKenzie Becker, Jonathan M. Haldeman, Svetha Swaminathan, and Samuel B. Stephens. Chromogranin b regulates early-stage insulin granule trafficking from the golgi in pancreatic islet β-cells. Journal of Cell Science, July 2019. URL: http://dx.doi.org/10.1242/jcs.231373, doi:10.1242/jcs.231373. This article has 42 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.231373)

[13. (Wang2022Value) Yong Wang, Danlei Chen, Yingxian Pang, Xiaowen Xu, Xiao Guan, and Longfei Liu. Value of immunohistochemical expression of apelin, succinate dehydrogenase b, chromogranin b, human epidermal growth factor receptor-2, contactin 4, and succinyl-coa synthetase subunit beta in differentiating metastatic from non-metastatic pheochromocytoma and paraganglioma. Frontiers in Endocrinology, April 2022. URL: http://dx.doi.org/10.3389/fendo.2022.882906, doi:10.3389/fendo.2022.882906. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2022.882906)